BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,041 | -93.8% | 5,200 | -36.6% | 0.00% | – |
Q2 2023 | $16,892 | -37.6% | 8,200 | 0.0% | 0.00% | – |
Q1 2023 | $27,060 | +101.2% | 8,200 | 0.0% | 0.00% | – |
Q4 2022 | $13,448 | -62.6% | 8,200 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $36,000 | +100.0% | 8,200 | +22.4% | 0.00% | – |
Q2 2022 | $18,000 | -30.8% | 6,700 | -13.0% | 0.00% | – |
Q1 2022 | $26,000 | -33.3% | 7,700 | -20.6% | 0.00% | -100.0% |
Q4 2021 | $39,000 | -30.4% | 9,700 | -42.9% | 0.00% | 0.0% |
Q3 2021 | $56,000 | -22.2% | 17,000 | -10.5% | 0.00% | 0.0% |
Q2 2021 | $72,000 | -100.0% | 19,000 | -69.2% | 0.00% | -50.0% |
Q1 2021 | $235,928,000 | +341824.6% | 61,600 | +302.6% | 0.00% | +100.0% |
Q4 2020 | $69,000 | -84.0% | 15,300 | -39.8% | 0.00% | -90.9% |
Q3 2020 | $430,000 | +54.7% | 25,400 | +2.4% | 0.01% | +37.5% |
Q2 2020 | $278,000 | +212.4% | 24,800 | +28.5% | 0.01% | +166.7% |
Q1 2020 | $89,000 | +535.7% | 19,300 | +451.4% | 0.00% | – |
Q4 2019 | $14,000 | +55.6% | 3,500 | +40.0% | 0.00% | – |
Q3 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
Q2 2019 | $9,000 | -60.9% | 2,500 | -58.3% | 0.00% | -100.0% |
Q3 2018 | $23,000 | +155.6% | 6,000 | +100.0% | 0.00% | 0.0% |
Q1 2018 | $9,000 | -18.2% | 3,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $11,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 242,850 | $923,000 | 0.13% |
ABNER HERRMAN & BROCK LLC | 241,500 | $918,000 | 0.13% |
Weaver Consulting Group | 48,881 | $186,000 | 0.10% |
Tibra Equities Europe Ltd | 87,000 | $331,000 | 0.10% |
Ikarian Capital, LLC | 293,200 | $1,115,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 60,238 | $229,000 | 0.03% |
Ergoteles LLC | 124,329 | $472,000 | 0.01% |
CFO4Life Group, LLC | 12,003 | $46,000 | 0.01% |
HighPoint Advisor Group LLC | 17,033 | $65,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 32,836 | $125,000 | 0.00% |